SOURCE: StockCall

StockCall

July 15, 2011 08:59 ET

Research on PDL BioPharma Inc. and Biogen Idec Inc. - Biotechnology Sector Always Interesting and Volatile

JOHANNESBURG, SOUTH AFRICA--(Marketwire - Jul 15, 2011) - www.stockcall.com/ offers investors comprehensive research on the Biotechnology industry and has completed analytical research on PDL BioPharma Inc. (NASDAQ: PDLI) and Biogen Idec Inc. (NASDAQ: BIIB). Register with us today at www.stockcall.com/ to have free access to these researches.

The Biotechnology sector can be very difficult to track as a whole because of its volatile and individual nature. Developments regarding government approvals, litigation, and discoveries all have the ability to elicit large movements in stock prices. One example of a company that could potentially see a breakout is Biogen Idec Inc. Investors looking for free research on Biogen Idec Inc. are welcome to sign up at www.stockcall.com/BIIB1507611.pdf.

www.stockcall.com/ is an online platform where investors doing their due-diligence on the Biotechnology industry can have easy and free access to our analyst research and opinions on PDL BioPharma Inc. and Biogen Idec Inc.; all investors need to do is register for a complimentary membership at https://stockcall.com/development/stockcall/page.php?name=register.html.

Biogen has suggested that it may have discovered a new way to treat multiple sclerosis. The sector is looking hard for new drugs as it prepares for looming patent cliffs. This company which has been on a strong run lately could see even more benefit if its drug Fampyra is finally approved by the European Union. Register now at https://stockcall.com/development/stockcall/page.php?name=register.html to have free access to our reports on the Biotechnology industry.

Elsewhere, shares of PDL Biopharma Inc. got a boost when a Nevada court did not dismiss its patent suit against Roche Holdings and Genentech over royalties. This sort of litigation is common in the sector and generally very difficult to forecast. Investors that are able to predict any of the swing-inducing events could reap huge rewards. Investors looking for free research on PDL BioPharma Inc. are welcome to sign up at www.stockcall.com/PDLI15D0711.pdf.

Visit www.stockcall.com/ to see how companies in this industry have grown over the past years and how they are expected to perform in the future.

About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information